PP
PDT Partners’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-81,835
| Closed | -$893K | – | 690 |
|
|
2022
Q4 | $893K | Sell |
81,835
-44,203
| -35% | -$482K | 0.14% | 256 |
|
|
2022
Q3 | $1.06M | Buy |
126,038
+37,460
| +42% | +$316K | 0.16% | 203 |
|
|
2022
Q2 | $701K | Buy |
88,578
+72,610
| +455% | +$575K | 0.06% | 511 |
|
|
2022
Q1 | $378K | Sell |
15,968
-50
| -0.3% | -$1.18K | 0.03% | 648 |
|
|
2021
Q4 | $548K | Sell |
16,018
-13,682
| -46% | -$468K | 0.04% | 506 |
|
|
2021
Q3 | $526K | Buy |
+29,700
| New | +$526K | 0.04% | 466 |
|
|
2020
Q2 | – | Sell |
-31,421
| Closed | -$222K | – | 790 |
|
|
2020
Q1 | $222K | Sell |
31,421
-11,985
| -28% | -$84.7K | 0.02% | 539 |
|
|
2019
Q4 | $306K | Buy |
43,406
+23,785
| +121% | +$168K | 0.02% | 536 |
|
|
2019
Q3 | $236K | Buy |
19,621
+4,610
| +31% | +$55.4K | 0.01% | 397 |
|
|
2019
Q2 | $182K | Buy |
+15,011
| New | +$182K | 0.01% | 373 |
|
|
2018
Q1 | – | Sell |
-30,266
| Closed | -$630K | – | 597 |
|
|
2017
Q4 | $630K | Buy |
30,266
+4,366
| +17% | +$90.9K | 0.02% | 403 |
|
|
2017
Q3 | $458K | Buy |
25,900
+8,500
| +49% | +$150K | 0.02% | 439 |
|
|
2017
Q2 | $197K | Sell |
17,400
-600
| -3% | -$6.79K | 0.01% | 484 |
|
|
2017
Q1 | $231K | Buy |
+18,000
| New | +$231K | 0.01% | 436 |
|